Trial Profile
A study investigating the effect of febuxostat in gout and hyperuricemia patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- 01 Sep 2015 New trial record